The American Gastroenterological Association and Varia Ventures have launched a new fund to invest in fast-growing, early-stage companies in the GI space. The fund will speed innovations from concept to clinic for the benefit of patients with digestive disease, according to an AGA news release.
GI innovators often face a funding gap at the earliest stages of development; strategic investments of $250K to $2M could make their idea successful – but most venture capital (VC) firms do not fund such early-stage innovation. The GI Opportunity Fund seeks to fill that gap by connecting GI innovators with GI investors. Read more.
